Compare PCVX & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCVX | ULS |
|---|---|---|
| Founded | 2013 | 1894 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 18.2B |
| IPO Year | 2020 | 2023 |
| Metric | PCVX | ULS |
|---|---|---|
| Price | $58.39 | $96.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $88.25 | ★ $88.85 |
| AVG Volume (30 Days) | ★ 1.6M | 976.3K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $3,053,000,000.00 |
| Revenue This Year | N/A | $6.29 |
| Revenue Next Year | N/A | $5.67 |
| P/E Ratio | ★ N/A | $215.91 |
| Revenue Growth | N/A | ★ 6.38 |
| 52 Week Low | $29.10 | $61.95 |
| 52 Week High | $65.00 | $107.54 |
| Indicator | PCVX | ULS |
|---|---|---|
| Relative Strength Index (RSI) | 66.66 | 50.82 |
| Support Level | $42.30 | $95.07 |
| Resistance Level | $58.95 | $103.99 |
| Average True Range (ATR) | 2.50 | 3.48 |
| MACD | 1.06 | 0.42 |
| Stochastic Oscillator | 91.36 | 62.29 |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.